Pregnancy is an exciting journey, and knowing your baby’s gender can be one of the first milestones parents look forward to. Prequel Genetics’ Six Weeks Early Gender Test offers a safe, non-invasive method to determine fetal sex as early as the 6th week of pregnancy using a simple maternal blood sample.
How the Test Works
The test analyzes free placental DNA circulating in maternal blood. Using the TaqMan assay, the presence or absence of the SRY gene and the DYS14 sequence — both markers of the Y chromosome — is detected.
- Presence of SRY/DYS14: Indicates a male fetus
- Absence of SRY/DYS14: Suggests a female fetus
This method allows for early sex determination without the need for invasive procedures.
Key Considerations
While the test is non-invasive and poses no risk to the fetus, it is important to understand its limitations:
- The amount of placental DNA in maternal blood can vary, potentially affecting accuracy
- Fetoplacental mosaicism (presence of multiple cell lines) may alter results
- PCR amplification failure can lead to inconclusive or incorrect findings
Because of these factors, the Six Weeks Test is a screening tool, not a diagnostic test. Confirmatory prenatal diagnosis remains possible only through invasive procedures such as chorionic villus sampling or amniocentesis.
Reliability and Safety
The Six Weeks Early Gender Test is designed to provide early, actionable information about fetal sex. It is highly accurate when performed according to protocol, and being blood-based, it is completely safe for both mother and fetus.
Conclusion
The Six Weeks Early Gender Test allows expectant parents to discover their baby’s gender earlier than ever before, with minimal risk and maximum convenience. While it is a screening test and not a diagnostic tool, it provides valuable information that can help parents and clinicians make informed decisions from the very beginning of pregnancy.